Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-07-05
1976-08-24
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2523011R, 25230115, 2605025, 424211, A61K 4300, G21H 502
Patent
active
039767620
ABSTRACT:
Chemical complexes, useful as radiopharmaceuticals, are formed by reacting technetium-99m with substituted or unsubstituted alkyl monophosphonic acids and certain ester derivatives thereof. The complexes are formed by reducing pertechnetate ion chemically or electrolytically in the presence of the phosphonic acid. By chemical modification of the phosphonic acid complexing agent, it is possible to "tailor" complexes for kidney, liver or bone imaging. The complexes are normally used in a physiologically acceptable aqueous medium.
REFERENCES:
patent: 3600470 (1971-08-01), Lewis
patent: 3725295 (1973-04-01), Eckelman et al.
patent: 3735001 (1973-05-01), McRae et al.
patent: 3851044 (1974-11-01), Adler et al.
patent: 3852414 (1974-12-01), Adler et al.
Subrumanian et al., Radiology, vol. 102, Mar., 1972, pp. 701-704.
Kohler Gunter A.
Pestel Gary M.
Minnesota Mining and Manufacturing Company
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Multi-organ technetium complexes production and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multi-organ technetium complexes production and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multi-organ technetium complexes production and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-779416